Introduction: The benefits and risks of HMG-CoA reductase inhibitor (statin) drugs in survivors of intracerebral hemorrhage (ICH) are unclear. Observational studies suggest an association between statin use and increased risk of lobar ICH, particularly in patients with apolipoprotein-E (APOE) ε2 and ε4 genotypes. There are no randomized controlled trials addressing the effects of statins after ICH leading to uncertainty as to whether statins should be used in patients with lobar ICH who are at high risk for ICH recurrence. The SATURN trial aims to evaluate the effects of continuation versus discontinuation of statin on the risk of ICH recurrence and ischemic major adverse cerebro-cardio-vascular events (MACCEs) in patients with lobar ICH. Secondary aims include the assessment of whether the APOE genotype modifies the effects of statins on ICH recurrence, functional and cognitive outcomes, and quality of life. Methods: The SATURN trial is a multi-center, pragmatic, prospective, randomized, open-label, phase III clinical trial with blinded end-point assessment. A planned total of 1,456 patients with lobar ICH will be recruited from 140 sites in the USA, Canada, and Spain. Patients presenting within 7 days of a spontaneous lobar ICH that occurred while taking a statin will be randomized (1:1) to continuation (control) versus discontinuation (intervention) of the same statin drug and dose that they were using at ICH onset. The primary outcome is the time to recurrent symptomatic ICH within a 2-year follow-up period. The primary safety outcome is the occurrence of ischemic MACCE. Conclusion: The results will help to determine the best strategy for statin use in survivors of lobar ICH and may help to identify if there is a subset of patients who would benefit from or be harmed by statins.

1.
Selim
M
,
Foster
LD
,
Moy
CS
,
Xi
G
,
Hill
MD
,
Morgenstern
LB
, et al
.
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
.
Lancet Neurol
.
2019
;
18
(
5
):
428
38
.
2.
Lyden
PD
,
Shuaib
A
,
Lees
KR
,
Davalos
A
,
Davis
SM
,
Diener
HC
, et al
.
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial
.
Stroke
.
2007
;
38
(
8
):
2262
9
.
3.
Mayer
SA
,
Brun
NC
,
Begtrup
K
,
Broderick
J
,
Davis
S
,
Diringer
MN
, et al
.
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
.
N Engl J Med
.
2008
;
358
(
20
):
2127
37
.
4.
Fogelholm
R
,
Nuutila
M
,
Vuorela
AL
.
Primary intracerebral haemorrhage in the Jyvaskyla region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome
.
J Neurol Neurosurg Psychiatry
.
1992
;
55
(
7
):
546
52
.
5.
Inagawa
T
,
Ohbayashi
N
,
Takechi
A
,
Shibukawa
M
,
Yahara
K
.
Primary intracerebral hemorrhage in Izumo City, Japan: incidence rates and outcome in relation to the site of hemorrhage
.
Neurosurgery
.
2003
;
53
(
6
):
1283
98
; discussion 1297–1288.
6.
Bamford
J
,
Sandercock
P
,
Dennis
M
,
Burn
J
,
Warlow
C
.
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project: 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage
.
J Neurol Neurosurg Psychiatry
.
1990
;
53
(
1
):
16
22
.
7.
Weimar
C
,
Roth
M
,
Willig
V
,
Kostopoulos
P
,
Benemann
J
,
Diener
HC
.
Development and validation of a prognostic model to predict recovery following intracerebral hemorrhage
.
J Neurol
.
2006
;
253
(
6
):
788
93
.
8.
Boe
NJ
,
Hald
SM
,
Jensen
MM
,
Kristensen
LMB
,
Bojsen
JA
,
Elhakim
MT
, et al
.
Major cardiovascular events after spontaneous intracerebral hemorrhage by hematoma location
.
JAMA Netw Open
.
2023
;
6
(
4
):
e235882
.
9.
Sprugel
MI
,
Kuramatsu
JB
,
Volbers
B
,
Saam
JI
,
Sembill
JA
,
Gerner
ST
, et al
.
Impact of statins on hematoma, edema, seizures, vascular events, and functional recovery after intracerebral hemorrhage
.
Stroke
.
2021
;
52
(
3
):
975
84
.
10.
Siddiqui
FM
,
Langefeld
CD
,
Moomaw
CJ
,
Comeau
ME
,
Sekar
P
,
Rosand
J
, et al
.
Use of statins and outcomes in intracerebral hemorrhage patients
.
Stroke
.
2017
;
48
(
8
):
2098
104
.
11.
Mascitelli
L
,
Pezzetta
F
,
Goldstein
MR
.
Hemorrhagic stroke in the SPARCL study
.
Stroke
.
2008
;
39
(
11
):
e180
e181
. Author reply e181.
12.
Koch
S
.
Intracerebral hemorrhage: preventing recurrence of ICH-should statins be avoided
.
Nat Rev Neurol
.
2011
;
7
(
4
):
193
4
.
13.
Molina
CA
,
Selim
MH
.
Continued statin treatment after acute intracranial hemorrhage: fighting fire with fire
.
Stroke
.
2013
;
44
(
7
):
2062
3
.
14.
Bustamante
A
,
Montaner
J
.
Statin therapy should not be discontinued in patients with intracerebral hemorrhage
.
Stroke
.
2013
;
44
(
7
):
2060
1
.
15.
Goldstein
LB
.
Statin therapy should be discontinued in patients with intracerebral hemorrhage
.
Stroke
.
2013
;
44
(
7
):
2058
9
.
16.
Athyros
VG
,
Tziomalos
K
,
Karagiannis
A
,
Wierzbicki
AS
,
Mikhailidis
DP
.
Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association
.
Curr Opin Cardiol
.
2010
;
25
(
4
):
406
10
.
17.
Goldstein
LB
,
Toth
PP
,
Dearborn-Tomazos
JL
,
Giugliano
RP
,
Hirsh
BJ
,
Pena
JM
,
Vascular
B
,
Council on
C
,
Stroke
N
.
Aggressive LDL-C lowering and the brain: impact on risk for dementia and hemorrhagic stroke: a scientific statement from the American heart association
.
Arterioscler Thromb Vasc Biol
.
2023
;
43
(
10
):
e404
42
.
18.
Centers for Disease Control and Prevention (CDC)
.
Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003–2012
.
CDC/National Center for Health Statistics
;
2014
; p.
2021
.
19.
Amarenco
P
,
Bogousslavsky
J
,
Callahan
A
3rd
,
Goldstein
LB
,
Hennerici
M
,
Rudolph
AE
, et al
.
Stroke prevention by aggressive reduction in cholesterol levels I: high-dose atorvastatin after stroke or transient ischemic attack
.
N Engl J Med
.
2006
;
355
(
6
):
549
59
.
20.
Heart Protection Study Collaborative Group
.
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
.
Lancet
.
2002
;
360
(
9326
):
7
22
.
21.
Haussen
DC
,
Henninger
N
,
Kumar
S
,
Selim
M
.
Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage
.
Stroke
.
2012
;
43
(
10
):
2677
81
.
22.
Romero
JR
,
Preis
SR
,
Beiser
A
,
DeCarli
C
,
Viswanathan
A
,
Martinez-Ramirez
S
, et al
.
Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study
.
Stroke
.
2014
;
45
(
5
):
1492
4
.
23.
Pezzini
A
,
Grassi
M
,
Iacoviello
L
,
Zedde
M
,
Marcheselli
S
,
Silvestrelli
G
, et al
.
Multicenter study on cerebral haemorrhage in Italy I: serum cholesterol levels, HMG-CoA reductase inhibitors and the risk of intracerebral haemorrhage. The multicenter study on cerebral haemorrhage in Italy (MUCH-Italy)
.
J Neurol Neurosurg Psychiatry
.
2016
;
87
(
9
):
924
9
.
24.
Woo
D
,
Deka
R
,
Falcone
GJ
,
Flaherty
ML
,
Haverbusch
M
,
Martini
SR
, et al
.
Apolipoprotein E, statins, and risk of intracerebral hemorrhage
.
Stroke
.
2013
;
44
(
11
):
3013
7
.
25.
Dowlatshahi
D
,
Demchuk
AM
,
Fang
J
,
Kapral
MK
,
Sharma
M
,
Smith
EE
, et al
.
Registry of the Canadian Stroke N: association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage
.
Stroke
.
2012
;
43
(
6
):
1518
23
.
26.
Flint
AC
,
Conell
C
,
Rao
VA
,
Klingman
JG
,
Sidney
S
,
Johnston
SC
, et al
.
Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition
.
JAMA Neurol
.
2014
;
71
(
11
):
1364
71
.
27.
Indraswari
F
,
Wang
H
,
Lei
B
,
James
ML
,
Kernagis
D
,
Warner
DS
, et al
.
Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach
.
J Neurotrauma
.
2012
;
29
(
7
):
1388
400
.
28.
Yang
D
,
Zhang
J
,
Han
Y
,
James
E
,
Chopp
M
,
Seyfried
DM
.
Acute statin treatment improves recovery after experimental intracerebral hemorrhage
.
World J Neurosci
.
2013
;
3
(
2
):
69
75
.
29.
Winkler
J
,
Shoup
JP
,
Czap
A
,
Staff
I
,
Fortunato
G
,
McCullough
LD
, et al
.
Long-term improvement in outcome after intracerebral hemorrhage in patients treated with statins
.
J Stroke Cerebrovasc Dis
.
2013
;
22
(
8
):
e541
5
.
30.
Tapia-Perez
JH
,
Rupa
R
,
Zilke
R
,
Gehring
S
,
Voellger
B
,
Schneider
T
.
Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage
.
Neurosurg Rev
.
2013
;
36
(
2
):
279
87
; discussion 287.
31.
Westover
MB
,
Bianchi
MT
,
Eckman
MH
,
Greenberg
SM
.
Statin use following intracerebral hemorrhage: a decision analysis
.
Arch Neurol
.
2011
;
68
(
5
):
573
9
.
32.
Cholesterol Treatment Trialists’ CTT Collaboration
;
Baigent
C
,
Blackwell
L
,
Emberson
J
,
Holland
LE
,
Reith
C
,
Bhala
N
, et al
.
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials
.
Lancet
.
2010
;
376
(
9753
):
1670
81
.
33.
McKinney
JS
,
Kostis
WJ
.
Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials
.
Stroke
.
2012
;
43
(
8
):
2149
56
.
34.
Asberg
S
,
Eriksson
M
.
Statin therapy and the risk of intracerebral haemorrhage: a nationwide observational study
.
Int J Stroke: Official Journal Int Stroke Soc
.
2015
;
10
(
Suppl A100
):
46
9
.
35.
Jung
JM
,
Choi
JY
,
Kim
HJ
,
Seo
WK
.
Statin use in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis
.
Int J Stroke
.
2015
;
10
(
Suppl A100
):
10
7
.
36.
Tai
SY
,
Lin
FC
,
Lee
CY
,
Chang
CJ
,
Wu
MT
,
Chien
CY
.
Statin use after intracerebral hemorrhage: a 10-year nationwide cohort study
.
Brain Behav
.
2016
;
6
(
8
):
e00487
.
37.
Saliba
W
,
Rennert
HS
,
Barnett-Griness
O
,
Gronich
N
,
Molad
J
,
Rennert
G
, et al
.
Association of statin use with spontaneous intracerebral hemorrhage: a cohort study
.
Neurology
.
2018
;
91
(
5
):
e400
9
.
38.
Ziff
OJ
,
Banerjee
G
,
Ambler
G
,
Werring
DJ
.
Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis
.
J Neurol Neurosurg Psychiatry
.
2019
;
90
(
1
):
75
83
.
39.
Ribe
AR
,
Vestergaard
CH
,
Vestergaard
M
,
Pedersen
HS
,
Prior
A
,
Lietzen
LW
, et al
.
Statins and risk of intracerebral hemorrhage in individuals with a history of stroke
.
Stroke
.
2020
;
51
(
4
):
1111
9
.
40.
Collins
R
,
Armitage
J
,
Parish
S
,
Sleight
P
,
Peto
R
;
Heart Protection Study Collaborative Group
.
Heart Protection Study Collaborative G: effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions
.
Lancet
.
2004
;
363
(
9411
):
757
67
.
41.
Goldstein
LB
,
Amarenco
P
,
Szarek
M
,
Callahan
A
3rd
,
Hennerici
M
,
Sillesen
H
, et al
.
Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study
.
Neurology
.
2008
;
70
(
24 Pt 2
):
2364
70
.
42.
Hemphill
JC
3rd
,
Bonovich
DC
,
Besmertis
L
,
Manley
GT
,
Johnston
SC
.
The ICH score: a simple, reliable grading scale for intracerebral hemorrhage
.
Stroke
.
2001
;
32
(
4
):
891
7
.
43.
EAST 6
.
Statistical software for the design, simulation and monitoring clinical trials
.
Cambridge, MA
:
Cytel Inc.
;
2020
.
44.
Greenberg
SM
,
Eng
JA
,
Ning
M
,
Smith
EE
,
Rosand
J
.
Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage
.
Stroke
.
2004
;
35
(
6
):
1415
20
.
45.
Zia
E
,
Engstrom
G
,
Svensson
PJ
,
Norrving
B
,
Pessah-Rasmussen
H
.
Three-year survival and stroke recurrence rates in patients with primary intracerebral hemorrhage
.
Stroke
.
2009
;
40
(
11
):
3567
73
.
46.
Poon
MT
,
Fonville
AF
,
Al-Shahi Salman
R
.
Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis
.
J Neurol Neurosurg Psychiatry
.
2014
;
85
(
6
):
660
7
.
47.
O'Donnell
HC
,
Rosand
J
,
Knudsen
KA
,
Furie
KL
,
Segal
AZ
,
Chiu
RI
, et al
.
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage
.
N Engl J Med
.
2000
;
342
(
4
):
240
5
.
48.
Li
L
,
Poon
MTC
,
Samarasekera
NE
,
Perry
LA
,
Moullaali
TJ
,
Rodrigues
MA
, et al
.
Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies
.
Lancet Neurol
.
2021
;
20
(
6
):
437
47
.
49.
Kim
KH
,
Kim
HD
,
Kim
YZ
.
Comparisons of 30-day mortalities and 90-day functional recoveries after first and recurrent primary intracerebral hemorrhage attacks: a multiple-institute retrospective study
.
World Neurosurg
.
2013
;
79
(
3–4
):
489
98
.
50.
Shoamanesh
A
,
Selim
M
.
Use of lipid-lowering drugs after intracerebral hemorrhage
.
Stroke
.
2022
;
53
(
7
):
2161
70
.
51.
Bailey
RD
,
Hart
RG
,
Benavente
O
,
Pearce
LA
.
Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage
.
Neurology
.
2001
;
56
(
6
):
773
7
.
You do not currently have access to this content.